Early detection of pancreatic cancer (PC) is essential for a better prognosis. Some recent studies have demonstrated that a slight dilatation of the main pancreatic duct (MPD) and small cystic lesions were detected initially in most cases diagnosed at an early stage. Detecting these abnormal findings in cases with high risk factors through an effective screening system including image diagnosis, some biological markers, or familial cancer registrations should contribute to early diagnosis of PC. It has been reported that endoscopic ultrasonography (EUS) is essential for detecting tumors <10 mm with a favorable prognosis. Additionally, EUS-guided fine-needle aspiration biopsy is useful for confirming final histological diagnosis. For the diagnosis of stage 0 PC, local irregular stenosis of MPD should be an important initial abnormal sign detected by EUS or magnetic resonance cholangiopancreatography.
| INTRODUCTION
Many patients with pancreatic cancer (PC) with a poor prognosis are diagnosed at an advanced stage. This is attributed to the difficulty of early diagnosis of PC. 1, 2 According to the recent Japan Pancreatic Cancer Registry (JPCR) analyzed by Japan Pancreas Society (JPS), the 5-year survival rate of cases with tumors ≤10 mm (TS1a) reached 80.4%, and the 5-year survival rate of cases with Stage 0 reached 85.8%. 3 These data suggest that early diagnosis should play an important role in improving the prognosis of PC. In this manuscript, we would like to review the current trends and concerns of early diagnosis of PC.
| OPPORTUNITY TO DIAGNOSE ' EAR LY PANCRE ATIC CANCER'
Hruban et al. first reported a genetic progression model from the precursor lesions named pancreatic intraepithelial neoplasia (PanIN) to PC. 4 According to their progressions, the extent of atypia was classified as PanIN-1 (low-grade dysplasia), PanIn-2 (moderate-grade dysplasia), and PanIN-3 (high-grade dysplasia). Cases with PC in situ (PCIS) are classified into PanIN-3. It has been reported that K-ras mutations in PanIN-1, p16 inactivating mutations in PanIN-2, TP53
These observations should support a genetic progression model of pancreatic carcinogenesis leading to invasive cancer. [5] [6] [7] [8] [9] [10] Recently, the estimated lifetime of clonal evolution during PC development and progression based on a computational model using many autopsy cases has been reported. 11, 12 This model suggested an average of 11.7 years from the initiating carcinogenesis until development of the parental clone, an average of 6.8 years to the development of metastatic subclones within the primary PC, and an average of 2.7 years until death of the case (Figure 1 
| Family history and hereditary PC syndrome
According to the registry of the National Familial Pancreas Tumor Registry (NFPTR), the risk of PC was 6.8-fold higher in the relatives of cases with familial PC, and 2.4-fold higher in relatives of cases with sporadic PC. 31 It has been reported that BRCA2, PALB2, and ataxia telangiectasia mutated germ-line mutations are most frequently identified in familial PC cases. [32] [33] [34] In July 2013 in Japan, JPS established the familial PC registry for early diagnosis, and already started this registry in 2015.
Recently, several genetic risk factors and syndromes have been 
| 45
Several initial screening studies using magnetic resonance imaging (MRI) or endoscopic ultrasonography (EUS) have been carried out in cases with genetic risk factors and syndromes, demonstrating some initial potential in identifying PC and premalignant lesions with malignant potential. [40] [41] [42] In 2016, these hereditary diseases will be newly added to risk factors for PC in the revised CGL issued by JPS Working Group (Table 3) .
| POTENTIAL BIOMARKERS FOR EARLY DIAGNOSIS
At present, some serum markers such as CA19-9, carcinoembryonic antigen (CEA) and DUPAN-2 have been commonly used. However, these markers are not useful for early diagnosis of PC. 43, 44 Recently, 48 Kojima et al. 49 reported a diagnostic index using expression profiles of the 10 most significant miRNAs, and that the assessment of these markers would be clinically valuable to identify resectable cases of PC. Recently, Gerdtsson et al.
reported recombinant antibody microarrays identifying serum protein markers associated with different tumor locations in the pancreas. 50 As for the endoscopic approach, a minimally invasive and simple screening test for early diagnosis of PC using duodenal juice (DJ) has been reported. The sensitivity of S100P in DJ to diagnose PC was higher than that of serum tumor or cytology using pancreatic juice. 51 were diagnosed at first examination, and seven IPMN-concomitant PC were diagnosed during follow-up periods. 29 These observations suggest that EUS should have important roles in the early diagnosis of PC. Recently, JPS first published a recommendation for early diagnosis of PC with a favorable long prognosis in the current CGL as follows.
| SCREE NIN G PR OGRAMS FOR HIGH-RISK CASES
14 Dilatation of the main pancreatic duct and the presence of cysts are important indirect signs. MRCP and EUS are recommended even when US and CT fail to directly detect a mass lesion. In 2016, the algorithm for diagnosis of PC will be improved in revised CGL issued by JPS Working Group. EUS will be recommended as the second-step examination for diagnosis of PC ( Figure 2 ).
| REGION AL NETWORKS FOR EARLY DIAGNOSIS OF PC (ONOMICHI PROJECT)
It has been reported that regional networks between specialists in PC (SPC) and general practitioners (GP) should play an important role for early diagnosis of PC. Onomichi city is a rural city located As a result, 399 out of 6475 cases were histologically diagnosed as PC. Of these cases, 16 were finally diagnosed as PCIS. 56 As the concept of the Onomichi project spreads, some Japanese medical associations have tried to establish the regional network for early diagnosis of PC. In the future, regional networks between SPC and GP in medical associations for early diagnosis of PC should be established in other rural areas in Japan.
| DIAGNOSIS OF PCIS
According to a recent JPCR by JPS, the 5-year survival rate of cases with UICC Stage 0 is 85.8%, which is a satisfactory prognosis. 3 However, it has been difficult to diagnose PCIS without the presence of a formed mass lesion by any imaging modalities. As for the early state of invasive PC, Ikeda et al. reported that the non-invasive cancer parts of invasive PC were classified into three types: flat (F), low papillary (LP) and mixed (FLP). Interestingly, the LP type had a greater tendency than the F type to spread intraductally. The LP type seemed to change to invasive cancer after or while spreading intraductally to some extent, whereas the F type seemed to invade with little intraductal spread. 57 In cases with pTS1 (histologically ≤2 cm in diameter), the frequency of intraductal spread of PC was high. 58, 59 Understanding these processes of growth and development of PC with an early stage should contribute to the diagnosis of PCIS. reported that three out of 14 cases with PCIS had a high degree of fatty changes of the pancreatic parenchyma adjacent to PCIS, which were recognized on CT. 63 There have been some interesting reports about pathological findings of PCIS using resected specimens. Localized pancreatitis with infiltration of inflammatory cells, fibrosis, and fatty infiltration were frequently observed in the parenchyma around PCIS and atypical epithelium. In addition, there were some PCIS cases with intraductal spread, and mismatch of cancer and MPD stenosis. 56, [63] [64] [65] [66] [67] [68] [69] EUS could detect localized pancreatitis, fibrosis, and F I G U R E 5 Magnetic resonance cholangiopancreatography findings of pancreatic cancer in situ (PCIS). Localized stenosis with distal dilatation, irregularity, non-continuous narrowing, focal ductal branch dilatations and cystic lesions around the main pancreatic duct are observed. Red dot, PCIS; yellow dot, atypical epithelium F I G U R E 6 Summary of image and pathological findings of PCIS. MPD, main pancreatic duct; PanIN, pancreatic intraductal neoplasm; PCIS, pancreatic cancer in situ fatty infiltration around PCIS as a slightly low echoic lesion. 56, 66 Further examinations will be needed to confirm these possibilities in the future ( Figure 6 ).
For pathological diagnosis of PCIS, cytodiagnosis using pancreatic juice (PJ) during ERCP has been reported to be useful. Recently, there have been some reports of cytodiagnosis multiple times using PJ obtained by ENPD. The sensitivity and accuracy for diagnosis of PCIS using this method was 100%, and 95%, respectively. 64, 70, 71 Current Japanese CGL for PC recommends cytodiagnosis multiple times using PJ during ERCP when localized stenosis of MPD is observed by MRCP, EUS, or ERCP. 14 
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